IONETIX, a leading cyclotron technology and isotope manufacturing company,  announced that the FDA approval was received for N-13 Ammonia manufacturing at Adler Institute for Advanced Imaging in Jenkintown PA. Adler Imaging has been an independent PET/CT facility serving the greater Philadelphia area for nearly twenty years, priding themselves on bringing cutting edge diagnostics to the community. Adler Imaging will be using the N-13 Ammonia manufactured by IONETIX to perform Cardiac PET imaging. Cardiac PET is used to diagnose, and risk stratify patients with coronary artery disease (CAD). The superior image quality of N-13 Ammonia and the ability to perform quantitative analysis is why it is considered the “gold standard” of non-invasive cardiac imaging for the detection and evaluation of CAD.

To read more please visit:

IONETIX Announces FDA approval for N-13 Ammonia manufacturing in the Philadelphia area

Source: IONETIX